Ads
related to: abt stock price quote- MarketWatch.com
MarketWatch Provides The Latest
Stock Market & Business News.
- Investing
See The News, Analysis And
Advice On Investing Here.
- Economy & Politics
Learn About The Impact Of Current
Events On The Economy Today.
- Personal Finance
Read The Latest Stories On What The
Financial News Of The Day Means.
- MarketWatch.com
Search results
Abbott Laboratories (NYSE:ABT) stock performs better than its underlying earnings growth over last...
Simply Wall St. via Yahoo Finance· 10 months agoStock pickers are generally looking for stocks that will outperform the broader market. And while...
Investing in Abbott Laboratories (NYSE:ABT) five years ago would have delivered you a 42% gain
Simply Wall St. via Yahoo Finance· 7 months agoWhile Abbott Laboratories (NYSE:ABT) shareholders are probably generally happy, the stock hasn't had...
Should You Buy Abbott Laboratories (ABT) Ahead of Earnings?
Zacks via Yahoo Finance· 4 months agoInvestors are always looking for stocks that are poised to beat at earnings season and Abbott...
Abbott (ABT) EPD Business Grows Strong, Macro Issues Stay
Zacks via Yahoo Finance· 1 year agoAbbott Laboratories’ ABT branded generics and international diabetes businesses should drive growth...
Abbott (ABT) EPD Sales Aid Growth Amid Currency Headwind
Zacks via Yahoo Finance· 11 months agoAbbott’s ABT new product launches and acquisitions are expected to boost its sales. However, the...
What's in Store for Abbott Laboratories (ABT) in Q4 Earnings?
Zacks via Yahoo Finance· 4 months agoAbbott Laboratories ABT is slated to report its fourth-quarter 2023 results on Jan 24 before market...
Abbott (ABT) Medical Devices Arm Gains Traction, FX Woe Stays
Zacks via Yahoo Finance· 2 years agoAbbott Laboratories ABT is well poised for growth in the coming quarters, backed by its progress in...
Abbott (ABT) EPD Growth Continues Amid Macroeconomic Challenges
Zacks via Yahoo Finance· 1 year agoAbbott ABT is gaining from new product launches and strategic acquisitions. Yet, due to...
Abbott Laboratories (NYSE:ABT) shareholders have earned a 15% CAGR over the last five years
Simply Wall St. via Yahoo Finance· 1 year agoWhen we invest, we're generally looking for stocks that outperform the market average. Buying...
Abbott (ABT) to Commercialize Biosimilars in Emerging Markets
Zacks via Yahoo Finance· 8 months agoAbbott ABT recently announced an agreement with the leading international biopharmaceutical company,...